MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT ...

The Quadra Allure MP ™ CRT-P now offers patients the flexibility to undergo full-body diagnostic MRI scans for other conditions ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a ...

The average price paid by hospitals for cardiac implantable resynchronization pacemakers has dropped 12% over the last year, according to the most recent Modern Healthcare/ECRI Institute Technology ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may have comparable efficacy and more cost efficiency compared with a defibrillator, according ...

St. Jude ($STJ) thinks it has built a better pacemaker, an ongoing obsession of the medical device giants in pursuit of defending their market turf. The company has ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Washington, DC - The US Food and Drug Administration has approved two Biotronik cardiac-resynchronization-therapy pacemaker (CRT-P) generators, including one with an integrated home-monitoring system, ...

ROCHESTER, NY — Some patients with "normalized" LV function when their primary-prevention defibrillating cardiac-resynchronization-therapy device (CRT-D) nears the end of its service life may safely ...